Insiders who reported open-market trades in the last 12 months at the companies Scott B. Willoughby files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Scott B. Willoughby is a corporate insider, tracked as SVP, CHIEF LEGAL OFFICER, SECY of SANGAMO THERAPEUTICS, INC (SGMO). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Scott B. Willoughby last file a Form 4?
The most recent primary Form 4 on record is dated 27 May 2026, one of 11 filings going back to 2024.
Scott B. Willoughby is SVP, CHIEF LEGAL OFFICER, SECY of SANGAMO THERAPEUTICS, INC (SGMO). 11 SEC Form 4 filings on record going back to 2024, most recently on 27 May 2026.
Recent transactions
12
The latest 12 SEC Form 4 transactions reported by Scott B. Willoughby.
InsiderAlpha's records for Scott B. Willoughby go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
